beta-lactams has been researched along with stilbenes in 6 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (stilbenes) | Trials (stilbenes) | Recent Studies (post-2010) (stilbenes) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 13,935 | 245 | 7,836 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Coy, DH; Fuselier, JA; Hocart, SJ; Sun, L; Vasilevich, NI | 1 |
Bright, SA; Carr, M; Carroll, P; Conneally, E; Croke, A; Fayne, D; Gagliardi, M; Greene, LM; Keely, NO; Lawler, M; Lloyd, DG; McElligott, AM; Meegan, MJ; Nathwani, SM; O'Boyle, NM; O'Connor, L; Sarkadi, B; Zisterer, DM | 1 |
Carr, M; Greene, LM; Knox, AJ; Lloyd, DG; Meegan, MJ; Zisterer, DM | 1 |
Fayne, D; Greene, LM; Malebari, AM; Meegan, MJ; Nathwani, SM; O'Boyle, NM; Twamley, B; Wang, S; Zisterer, DM | 1 |
Ding, K; Feng, K; Jiang, H; Liang, Y; Liu, M; Luo, C; Wang, J; Wang, X; Wang, Y; Xu, P; Zhang, H; Zhou, P | 1 |
Fayne, D; Malebari, AM; Meegan, MJ; Nathwani, SM; Noorani, S; O'Boyle, NM; O'Connell, F; O'Sullivan, J; Twamley, B; Zisterer, DM | 1 |
6 other study(ies) available for beta-lactams and stilbenes
Article | Year |
---|---|
Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design.
Topics: Animals; Antineoplastic Agents; Azetidines; Cell Line, Tumor; Humans; Mice; Mice, Nude; Models, Molecular; Rats; Stilbenes | 2004 |
The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Azetidines; beta-Lactams; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Guaiacol; HL-60 Cells; Humans; K562 Cells; Microscopy, Confocal; Microscopy, Fluorescence; Microtubules; Molecular Structure; Stereoisomerism; Stilbenes; Tubulin | 2010 |
Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Topics: Animals; Antineoplastic Agents; beta-Lactams; Cattle; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Conformation; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tubulin | 2010 |
β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; beta-Lactams; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; Glucuronates; HT29 Cells; Humans; Inactivation, Metabolic; Stilbenes; Structure-Activity Relationship | 2017 |
Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta-Lactams; Cell Cycle; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Mice; Mice, Inbred Strains; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Polymerization; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2018 |
β-Lactams with antiproliferative and antiapoptotic activity in breast and chemoresistant colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; beta-Lactams; Binding Sites; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; Humans; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Necrosis; Protein Binding; Stilbenes; Survivin; Tubulin; Tubulin Modulators | 2020 |